Wnt/-Catenin-Promoted Macrophage Alternative Activation Contributes to Kidney Fibrosis.

J Am Soc Nephrol

Department of Internal Medicine, Center for Kidney Disease, Second Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu, China

Published: January 2018

The Wnt/-catenin pathway is crucial in normal development and throughout life, but aberrant activation of this pathway has been linked to kidney fibrosis, although the mechanisms involved remain incompletely determined. Here, we investigated the role of Wnt/-catenin in regulating macrophage activation and the contribution thereof to kidney fibrosis. Treatment of macrophages with Wnt3a exacerbated IL-4- or TGF1-induced macrophage alternative (M2) polarization and the phosphorylation and nuclear translocation of STAT3 Conversely, inhibition of Wnt/-catenin signaling prevented these IL-4- or TGF1-induced processes. In a mouse model, induced deletion of -catenin in macrophages attenuated the fibrosis, macrophage accumulation, and M2 polarization observed in the kidneys of wild-type littermates after unilateral ureter obstruction. This study shows that activation of Wnt/-catenin signaling promotes kidney fibrosis by stimulating macrophage M2 polarization.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748914PMC
http://dx.doi.org/10.1681/ASN.2017040391DOI Listing

Publication Analysis

Top Keywords

kidney fibrosis
16
macrophage alternative
8
il-4- tgf1-induced
8
wnt/-catenin signaling
8
fibrosis
5
wnt/-catenin-promoted macrophage
4
activation
4
alternative activation
4
activation contributes
4
kidney
4

Similar Publications

Graphene Quantum Dots as Antifibrotic Therapy for Kidney Disease.

ACS Appl Bio Mater

January 2025

Department of Internal Medicine, College of Medicine, Seoul National University, Seoul 03080, Korea.

Graphene quantum dots (GQDs) have received much attention for their biomedical applications, such as bioimaging and drug delivery. Additionally, they have antioxidant and anti-inflammatory properties. We used GQDs to treat renal fibrosis and confirmed their ability to protect renal cells from excessive oxidative stress in vitro and in vivo.

View Article and Find Full Text PDF

Diabetic nephropathy (DN) is a major complication of diabetes and a leading cause of renal failure. While valsartan has been shown to alleviate DN clinically, its antifibrotic mechanisms require further investigation. This study used a transcriptomics-driven approach, integrating in vitro, Machine Learning, molecular docking, dynamics simulations and RT-qCPR to identify key antifibrotic targets.

View Article and Find Full Text PDF

Elevated Septal Native T1 Time in CMR Imaging Suggesting Myocardial Fibrosis in Young Kidney Transplant Recipients.

J Cardiovasc Magn Reson

January 2025

Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hannover, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Electronic address:

Background: Patients after kidney transplantation (KTx) in childhood show a high prevalence of cardiac complications, but the underlying mechanism is still poorly understood. In adults, myocardial fibrosis detected in cardiac magnetic resonance (CMR) imaging is already an established risk factor. Data for children after KTx are not available.

View Article and Find Full Text PDF

Background: Refractory ascites (RA) remains a serious complication in patients with cirrhosis. Currently, the insertion of a TIPS is considered the standard of care in these patients. To achieve symptom control in those with TIPS contraindications, tunneled peritoneal catheters (PeCa) or ascites pumps were introduced.

View Article and Find Full Text PDF

Disrupted feeding and fasting cycles as well as chronic high fat diet (HFD)-induced obesity are associated with cardiovascular disease risk factors. We designed studies that determined whether two weeks of time-restricted feeding (TRF) intervention in mice fed a chronic HFD would reduce cardiovascular disease risk factors. Mice were fed a normal diet (ND; 10% fat) ad libitum or HFD (45% fat) for 18 weeks ad libitum to establish diet-induced obesity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!